Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
These typically ease as the dose is gradually increased
Think of your intestines as a finely tuned orchestra of contractions that propel food along
This dual action helps lower blood glucose levels without causing hypoglycemia when glucose levels are normal
Suggested Use Take 1 tablespoon (15mL) before your workout or cardio session
Expanding Into New Indications GLP-1 therapies are now being explored in: - Fatty liver disease (MASLD) - Obstructive sleep apnea - Behavioral/metabolic disorders like binge eating This signals a shift toward whole-system metabolic management
Investor Takeaway For investors seeking exposure to the GLP-1 boom in India, the key is to identify companies with proven capabilities in: Peptide synthesis Sterile injectable manufacturing Global regulatory compliance CDMO services with US/EU clients Recommended Monitoring: R&D updates and capacity expansions Any tie-ups with global GLP-1 players Clinical trial progress for biosimilar versions Regulatory approvals (USFDA, EMA) Export data to key markets (USA, Canada, China) Conclusion The weight loss drug boom is changing global healthcare and creating a huge business opportunity for Indian pharma companies
US$ 23.47
US$ 25.86
US$ 29.60
